Zeria Pharmaceutical Co Ltd
TSE:4559
Zeria Pharmaceutical Co Ltd
Accounts Payable
Zeria Pharmaceutical Co Ltd
Accounts Payable Peer Comparison
Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Zeria Pharmaceutical Co Ltd
TSE:4559
|
Accounts Payable
¥3.3B
|
CAGR 3-Years
25%
|
CAGR 5-Years
13%
|
CAGR 10-Years
-1%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Accounts Payable
¥547.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Accounts Payable
¥557.1B
|
CAGR 3-Years
23%
|
CAGR 5-Years
12%
|
CAGR 10-Years
9%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Accounts Payable
¥193.4B
|
CAGR 3-Years
10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
4%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Accounts Payable
¥88.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
Astellas Pharma Inc
TSE:4503
|
Accounts Payable
¥185.2B
|
CAGR 3-Years
14%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
See Also
What is Zeria Pharmaceutical Co Ltd's Accounts Payable?
Accounts Payable
3.3B
JPY
Based on the financial report for Mar 31, 2024, Zeria Pharmaceutical Co Ltd's Accounts Payable amounts to 3.3B JPY.
What is Zeria Pharmaceutical Co Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
-1%
Over the last year, the Accounts Payable growth was 64%. The average annual Accounts Payable growth rates for Zeria Pharmaceutical Co Ltd have been 25% over the past three years , 13% over the past five years , and -1% over the past ten years .